The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I'm sure the is an 'N' missing in the ticker ACUT - just can't think where it would be though :-)
Cb1977
Thanks good post, roll on 2 weeks !
StarKnight
Latest update that I received in the past few days from the Accustem COO in case of use to anyone: We are currently in the process of finalizing DTC eligibility to enable AccuStem stock to trade under the ticker ACUT. We estimate that this will be completed within the next two weeks, and we will provide further information following completion of the DTC process.
Hi Denny
As these people we have working for us are well accomplished in this field , I would assume people would listen (meaning investors ) to what they have to say, and being accomplished sales people , do some good deals. I would expect!!!
Around 2 weeks to completion of the listing!
Denny11: How does that help them raise money? Surely that'll be done by a further share issue?
The higher the listing price the better for us.
The higher the price, the less dilution for us.
Hope that helps!
BB
Hi Cloudy390
hah hah hah well with the world in the state it is in anything could happen ! I feel so sorry for the Ukranian people that are suffering Genocide and we are standing watching them be exterminated by Dictator Putin !
Is it not a crime to watch a murder and not intervene ?
Sorry a bit off topic but so distraught
StarKnight
How does that help them raise money?
Surely that'll be done by a further share issue?
Bleed the mugs dry... :-)
Can't believe it but am actually 16 percent up this week. Long may it continue!!
lOl Starknight. I meant $25 as a starter , not euros!.
I’m either pressing the wrong button or my tablet has a mind of its own PMSL.
Rollon Alzheimer’s/Dementia trial as I may need it.
But hay Star !
Tils continuing its good recent run
@Cloudy390
Hi
do you mean $15 to $25 or as you have put in euros €25 ?
Cloudy
That would be great.
BB
As I understand it’s Wendy Blosser’s job to raise at least 30million and she and her management are extremely experienced in diagnostics and sales and it’s her job to get Accustem certified I would assume they will attract investment, so I would hope around $15/€25 would be achievable. That’s my estimation .
BB
No worries , exciting times await us all :-)
StarKnight
SK
I have absolutely no idea!
People have mentioned, £280m from a previous analysts note - 10% of $2.8b buyout of the competitor & we are 40% better - but not out there proving it! - Don't shoot the messenger.
Initial mcap for 10m shares at $5 could be $50m, but no cash.
Could we raise at $5 and have 50m shares with $200m in the bank to progress. That initial $50m valuation would rise substantially. Would someone buy that down the line for $1b when it is up & running with proof of success in a few hospitals, or do we wait longer for a higher bid but more dilution. Too many permutations.
It will be worth something shortly - but what??
Sorry - No help at all
BB
@Chuggley , Bluebelly and all
What is your educated best guess at the Accustem opening SP ? or erring on the safe side a range from $.... to $.... ?
StarKnight
Won't be long and imo $3 is a default from pink sheets. Will be higher than that
Understandable why so many investors here have been unhappy here, like many other investors i've kept quiet as have many Inst investors all unquestionably relying on original research...covid deviation, accustem spin off and lack of communication did us all no favours as did the screw up in the stuttered relocation of the stock listing.....anyway, thanks goodness we are back to the strong scientific fundamentals.....the most important reason for our original investment!
My son's SIPP- secure message today:
We wrote to you in September 2021 about Tiziana Life Sciences plan to convert to a Bermuda incorporated company with its shares listed on the NASDAQ stock market in the US.
This has completed and you’ve been given 1 new Bermuda incorporated share for every 2 shares held previously.
The new shares were originally issued outside of the UK settlement system (Crest) meaning we had to hold the shares with our global custodian, HSBC.
However, the shares are now eligible to be held in the UK in Crest. We have therefore automatically moved them into Crest meaning you can now trade them online and won’t have to pay the additional transaction charge referred to in our original correspondence.
Your SIPP was updated on 9 March 2022 on the following basis:'
BB
Big thumbs up to that.
BB
Bluebelly,Denny
I agree, we can't be far away from main listing now under ticker ACUT we could have exciting times ahead !
StarKnight
BB is about right. If you look at the $3 price page there is no history. IMO it's just set up waiting for data to be populated and $3 is the default (and the minimum IIRC)
Smell the coffee, Accustem 9mill shares 280mill worth. Do the maths , don’t sell it short, amazing new board, back em!!!
Hi Blueb
Many thanks , I knew you would have an idea lol,
in which case it may well be then that when we do launch the Sp may be $5.00 as per the Nasdaq minimum share price or even higher !
Link to Nasdaq Law info
https://www.findlaw.com/smallbusiness/business-finances/markets-and-listing-requirements.html#:~:text=NASDAQ%20National%20Market%20(NASDAQ)&text=Initial%20Minimum%20Bid%20Price%20for,remain%20at%20or%20above%20%241.00.
StarKnight